Senators Push Bill To Streamline Combination Product Approval

A group of senators is pushing legislation to streamline the FDA approval process for combination drug, device and companion diagnostic products -- a move praised by industry stakeholders as a good first step in addressing an issue they hope will be tackled by the Senate health committee's Innovation for Healthier Americans initiative. The move comes as the committee meets with stakeholder groups on its parallel to the House 21st Century Cures legislation. The Combination Product Regulatory Fairness Act of 2015...